Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check4 days agoChange DetectedThe page previously showing a 403 Forbidden message (and its HTML) was removed, likely restoring normal access to the study details content.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an access-denied message. This indicates the study details are currently unavailable on the page.SummaryDifference17%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a 'Multiple myeloma' topic tag and a MedlinePlus Genetics related topics reference; the site revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check39 days agoChange DetectedRemoved the related topics entries for 'Multiple Myeloma' and the 'MedlinePlus Genetics' link from the study's related topics section.SummaryDifference0.2%

- Check54 days agoChange DetectedMultiple myeloma has been added as a topic, and MedlinePlus Genetics is now listed under related topics. The page revision has been updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check61 days agoChange DetectedExplicit disease term 'Multiple myeloma' is removed from the study details, and the related topics section including the MedlinePlus Genetics link is deleted. This changes how users identify the study focus and locate related information.SummaryDifference0.2%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.